RGEN- Repligen Corporation
Repligen Corporation (RGEN) has 10 insiders with recent SEC Form 4 filings, including 3 buys and 23 sells. RGEN is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 99.0K | $12.53M | - | |
| Dir | 91.8K | $11.62M | - | |
| CEO | 54.2K | $6.87M | - | |
| VP | 20.1K | $2.54M | - | |
| Other | 8.5K | $1.08M | - |
Activity
Buys and sells only
Transactions
10 filings · page 3
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 16,707 | $197.44 | $3,298,632.04 | -1.1% | -24.0% | -20.3% | |
| Feb 27, 2024 | Dawes Karen A63 | Director | Sale+OE | 1,000 | $193.35 | $193,350.00 | -1.1% | -18.7% | -15.5% | |
| Feb 23, 2024 | Bylund James70 | Chief Operating Officer | Sale+OE | 4,373 | $198.08 | $866,203.84 | -23.6% | -19.2% | -19.1% | |
| Nov 10, 2023 | Gebski Christine62 | See Remarks | Sell | 3,788 | $147.13 | $557,328.44 | -11.6% | +38.2% | -4.6% | |
| Aug 29, 2023 | Dawes Karen A63 | Director | Sale+OE | 850 | $171.38 | $145,673.00 | -1.0% | -7.3% | -15.5% | |
| May 8, 2023 | Madaus Martin D72 | Director | Buy | 1,500 | $158.84 | $238,260.00 | +81.8% | +9.4% | +7.1% | |
| Feb 16, 2023 | Snodgres Jon59 | Chief Financial Officer | Sell | 5,647 | $200.00 | $1,129,400.00 | -16.1% | -22.8% | +5.2% | |
| Nov 11, 2022 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 25,000 | $200.00 | $5,000,000.00 | -12.3% | -6.6% | -26.0% | |
| Sep 9, 2022 | Dawes Karen A63 | Director | Sell | 775 | $227.17 | $176,056.75 | -1.0% | -25.6% | -30.9% | |
| Sep 8, 2022 | Hunt Anthony75 | Chief Executive Officer | Sale+OE | 26,402 | $224.73 | $5,933,438.25 | -1.7% | -25.0% | -28.9% |